vimarsana.com

Latest Breaking News On - Viva biotech holdings group - Page 2 : vimarsana.com

Viva Biotech (1873 HK) Announces 2023 Interim Results: Solid Growth in Main Business, Significant Rebound in Profitability

/PRNewswire/ On August 29, 2023, Viva Biotech Holdings Group ("Viva Biotech", "the Group" or "the Company", stock code: 1873.HK) announced that during the.

United statesUnited kingdomLanghua pharmaCheney maoSuccessful exit of incubation portfolio companiesOur computational chemistry departmentShanghai supercomputing centerViva biotech holdingsViva biotech holdings groupInterim resultsReporting periodHighlight capitalIncreasing numberLanghua pharmaceuticalViva biotechInvestment income

Viva Biotech Announced Strategic Investors with an Investment of Approximately US$ 210 Million

/PRNewswire/ On June 11, 2023, Viva Biotech Holdings Group (1873.HK) announced that Viva Shanghai, the primary entity for Viva Biotech s CRO business,.

Hong kongTemasek charterBaheal pharmaCheney maoViva biotech holdings groupViva biotech holdingsViva shanghaiViva biotechLanghua pharmaceuticalEmployee stock ownership planRelevant investorsEvery generationHighlight capitalFlight capitalUnited imagingWuxi biologics

vimarsana © 2020. All Rights Reserved.